From: Prognostic significance of ST3GAL-1 expression in patients with clear cell renal cell carcinoma
ST3gal-1 expression | ||||
---|---|---|---|---|
Characteristics | All patients | Low | High | p* |
Age (years) | 0.656 | |||
Mean ± SD | 55.0 ± 13.0 | 54.7 ± 13.6 | 55.4 ± 11.9 | |
Gender | 0.455 | |||
Female | 90 | 57 | 33 | |
Male | 196 | 115 | 81 | |
T stage | 0.913 | |||
T1 | 180 | 106 | 74 | |
T2 | 24 | 14 | 10 | |
T3 | 79 | 50 | 29 | |
T4 | 3 | 2 | 1 | |
N stage | 1.000 | |||
N0 | 284 | 171 | 113 | |
N1 | 2 | 1 | 1 | |
M stage | 0.102 | |||
M0 | 273 | 167 | 106 | |
M1 | 13 | 5 | 8 | |
TNM stage | 0.334 | |||
I | 176 | 105 | 71 | |
II | 20 | 12 | 8 | |
III | 75 | 49 | 26 | |
IV | 15 | 6 | 9 | |
Fuhrman nuclear grade grade | 0.604 | |||
1 | 31 | 19 | 12 | |
2 | 216 | 127 | 89 | |
3 | 37 | 24 | 13 | |
4 | 2 | 2 | 0 | |
Necrosis | 0.652 | |||
Absent | 249 | 151 | 98 | |
Present | 37 | 21 | 16 | |
ECOG PS | 0.587 | |||
0 | 198 | 117 | 81 | |
≥1 | 88 | 55 | 33 |